絞り込み

16997

広告

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial.

著者 Matthews DR , Paldánius PM , Proot P , Chiang Y , Stumvoll M , Del Prato S ,
Lancet.2019 Sep 17 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (46view , 0users)

Full Text Sources

Medical

Miscellaneous

Early treatment intensification leading to sustained good glycaemic control is essential to delay diabetic complications. Although initial combination therapy has been suggested to offer more opportunities than a traditional stepwise approach, its validity remains to be determined.
PMID: 31542292 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード